Research Content Services

customer support

Wolters Kluwer announces integration of DoseMeRx™ and Sentri7’s Antimicrobial Stewardship -

Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx™, a Tabula Rasa Healthcare precision dosing solution, with Sentri7’s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times.

Vancomycin is one of the most commonly used antibiotics in hospitals today. Traditionally, calculating vancomycin doses for patients requires coordination among pharmacists, nurses, and laboratory technicians, as well as manual calculations that are time-consuming. With the DoseMeRx integration, pharmacists have automated access to faster, more precise calculations, without any data entry, and proactively monitor for adjustments to reduce a patient’s risk of acute kidney injury.

In addition to the DoseMeRx real-time vancomycin dosing platform, pharmacists can leverage Sentri7’s evidence-based AMS rules to assess appropriate vancomycin use and keep prescribing in line with their hospital’s antimicrobial stewardship goals and the CDC’s Core Elements of Antimicrobial Stewardship program.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here to read the original press release.


  • |
  • |

sponsor links

For banner ads click here

STM Week - Innovations Seminar; STM Solutions Seminar; STM Day